{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:01:32Z","timestamp":1792008092569,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2107,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1038\/ki.2009.499","type":"journal-article","created":{"date-parts":[[2009,12,23]],"date-time":"2009-12-23T08:43:52Z","timestamp":1261557832000},"page":"543-549","source":"Crossref","is-referenced-by-count":168,"title":["Long-term study of mycophenolate mofetil treatment in IgA nephropathy"],"prefix":"10.1016","volume":"77","author":[{"given":"Sydney C.W.","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W.C.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny S.H.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.K.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiu Wing","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kar Neng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2009.499_bb0010","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMra020109","article-title":"IgA nephropathy","volume":"347","author":"Donadio","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2009.499_bb0015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ki.1996.116","article-title":"Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy","volume":"49","author":"Lai","year":"1996","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.499_bb0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ki.2008.636","article-title":"The ubiquitin-proteasome pathway and IgA nephropathy: a novel link?","volume":"75","author":"Tang","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.499_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1399-0012.1996.tb00651.x","article-title":"Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)","volume":"10","author":"Allison","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1038\/ki.2009.499_bb0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/ajkd.1998.v31.pm9469489","article-title":"Successful mycophenolate mofetil treatment of glomerular disease","volume":"31","author":"Briggs","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.499_bb0035","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1523-1755.2002.00214.x","article-title":"Mycophenolate mofetil treatment for primary glomerular diseases","volume":"61","author":"Choi","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.499_bb0040","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1523-1755.2005.00460.x","article-title":"Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy","volume":"68","author":"Tang","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.499_bb0045","first-page":"796","article-title":"A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy","volume":"82","author":"Chen","year":"2002","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1038\/ki.2009.499_bb0050","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1523-1755.2004.00588.x","article-title":"Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study","volume":"65","author":"Maes","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.499_bb0055","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/ndt\/gfh974","article-title":"Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial","volume":"20","author":"Frisch","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.499_bb0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000168483","article-title":"Mycophenolate mofetil treatment for IgA nephropathy: a meta-analysis","volume":"29","author":"Xu","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2009.499_bb0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1681\/ASN.V10169","article-title":"Apical proteins stimulate complement synthesis by cultured human proximal tubular epithelial cells","volume":"10","author":"Tang","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.499_bb0070","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1681\/ASN.V8101537","article-title":"Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein","volume":"8","author":"Wang","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.499_bb0075","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI16079","article-title":"Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo","volume":"111","author":"Tang","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.499_bb0080","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1046\/j.1523-1755.2002.00301.x","article-title":"Transferrin up-regulates chemokine synthesis by human proximal tubular epithelial cells: implication on mechanism of tubuloglomerular communication in glomerulopathic proteinuria","volume":"61","author":"Tang","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.499_bb0085","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0272-6386(96)90512-0","article-title":"The role of proteinuria in the progression of chronic renal failure","volume":"27","author":"Burton","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.499_bb0090","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1046\/j.1523-1755.2002.00380.x","article-title":"Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts","volume":"61","author":"Abbate","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.499_bb0095","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1523-1755.2004.00958.x","article-title":"Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells","volume":"66","author":"Wolf","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.499_bb0100","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.499_bb0105","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1681\/ASN.V12122832","article-title":"ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril efficacy in nephropathy","volume":"12","author":"Ruggenenti","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.499_bb0110","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1523-1755.2004.00873.x","article-title":"Idiopathic membranous nephropathy: definition and relevance of a partial remission","volume":"66","author":"Troyanov","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.499_bb0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/ncpneph0067","article-title":"Is mycophenolate mofetil an effective treatment for persistent proteinuria in patients with IgA nephropathy?","volume":"2","author":"Floege","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1038\/ki.2009.499_bb0120","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1291\/hypres.31.387","article-title":"Pathological regression by angiotensin II type 1 receptor blockade in patients with mesangial proliferative glomerulonephritis","volume":"31","author":"Ohtake","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1038\/ki.2009.499_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2369-5-3","article-title":"A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN6257616]","volume":"5","author":"Hogg","year":"2004","journal-title":"BMC Nephrol"},{"key":"10.1038\/ki.2009.499_bb0130","first-page":"136","article-title":"One-year angiotensin-converting enzyme inhibition plus mycophenolate mofetil immunosuppression in the course of early IgA nephropathy: a multicenter, randomised, controlled study","volume":"18","author":"Dal","year":"2005","journal-title":"J Nephrol"},{"key":"10.1038\/ki.2009.499_bb0135","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0272-6386(97)90456-X","article-title":"Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases","volume":"29","author":"Haas","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.499_bb0140","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0272-6386(00)70191-0","article-title":"Outcome of IgA nephropathy in adults graded by chronic histological lesions","volume":"35","author":"To","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.499_bb0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381554297X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381554297X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T16:38:37Z","timestamp":1739637517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381554297X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S008525381554297X"],"URL":"https:\/\/doi.org\/10.1038\/ki.2009.499","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.2809958.2474074","asserted-by":"object"}]},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}